Clinical equivalence of two tablet formulations of felodipine B. P. McGrathR. W. WattsD. B. Elmfeldt Clinical Trials Pages: 169 - 172
Polymorphic inhibition of human angiotensin I-converting enzyme by enalaprilat E. J. D. Lee Pharmacodynamics Pages: 173 - 175
The dihydropyridine calcium channel blocker BAY t 7207 attenuates the exercise induced increase in plasma ANF and cyclic GMP in patients with mildly impaired left ventricular function M. KentschG. Müller-EschV. Peinke Pharmacodynamics Pages: 177 - 182
Acute effects of the anxiolytics suriclone and alprazolam on cognitive information processing utilizing topographic mapping of event-related brain potentials (P300) in healthy subjects H. V. SemlitschP. AndererB. Saletu Pharmacodynamics Pages: 183 - 191
Renal and endocrine effects of flosulide, after single and repeated administration to healthy volunteers P. BrunelM. TurriA. Sioufi Pharmacodynamics Pages: 193 - 201
Relationship of changes in felodipine pharmacokinetics to haemodynamics during chronic oral treatment of congestive heart failure patients A. H. J. ScafH. WesselingP. H. J. M. Dunselman Pharmacokinetics and Disposition Pages: 203 - 210
4-Methylpyrazole monitoring during haemodialysis of ethylene glycol intoxicated patients H. FaesselJ. M. ScherrmannF. J. Baud Pharmacokinetics and Disposition Pages: 211 - 213
Disposition and uric acid lowering effect of oxipurinol: comparison of different oxipurinol formulations and allopurinol in healthy individuals I. Walter-SackJ. X. de VriesA. Voss Pharmacokinetics and Disposition Pages: 215 - 220
Single-dose pharmacokinetics of nefazodone in healthy young and elderly subjects and in subjects with renal or hepatic impairment R. H. BarbhaiyaD. S. GreeneU. A. Shukla Pharmacokinetics and Disposition Pages: 221 - 228
Steady-state pharmacokinetics of nefazodone in subjects with normal and impaired renal function R. H. BarbhaiyaM. E. BradyD. S. Greene Pharmacokinetics and Disposition Pages: 229 - 235
Pharmacokinetic characteristics and tolerability of a novel intravenous immunoglobulin preparation P. A. ThürmannC. Sonnenburg-ChatzopoulosR. Lissner Pharmacokinetics and Disposition Pages: 237 - 242
The tolerability, pharmacokinetics and lack of effect on plasma cholesterol of 447C88, an AcylCoA:Cholesterol Acyl Transferase (ACAT) inhibitor with low bioavailability, in healthy volunteers R. W. PeckR. WiggsJ. Posner Pharmacokinetics and Disposition Pages: 243 - 249